The best cure for premature ventricular tricyclic rhythm

There is no optimal cure for premature ventricular tricyclic rhythm, and treatment needs to be based on the patient’s condition and medical advice. Premature ventricular tricyclic rhythm can be caused by physiologic and pathologic reasons. Treatment includes medication and surgery. The appropriate treatment should be chosen according to whether the patient has organic heart disease and whether it affects cardiac output and whether it is a malignant arrhythmia. Transcatheter radiofrequency ablation may be curative. 1. Most of the premature ventricular tricyclic rhythms occurring in patients without organic heart disease do not require special treatment. These patients may be caused by exercise, exertion, alcohol consumption, etc. Lifestyle modification should be performed, and sedative drugs and beta-blockers such as metoprolol succinate extended-release tablets and metoprolol tartrate tablets may be given if necessary. 2. If the ventricular tricyclic rhythm is accompanied by organic lesions, the primary pathology should be treated first. For the treatment of ventricular premature beat drugs commonly used drugs β-blockers such as propranolol, metoprolol, etc.; calcium channel blockers diltiazem, verapamil, etc.. If the patient’s symptoms are severe, mesylate or propafenone may be given. Drugs conservative treatment, but often the effect is not good enough, the condition is easy to recur, can not achieve the goal of eradication. 3. Transcatheter radiofrequency ablation of ventricular ectopic pacing points can successfully treat or even cure ventricular premature. Patients with frequent ventricular premature beats with clinical symptoms, ventricular tachycardia, ventricular fibrillation and other cardiomyopathies can be evaluated by a physician for radiofrequency ablation. Anti-arrhythmic drugs should not be used without authorization in patients with mild or high risk. They should be used appropriately under the guidance of a physician to avoid adverse effects.